Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
2138299-34-8 | diABZI STING agonist-1 trihydrochloride | AA01FNMV | MFCD31746912
1203791-41-6 | Cycloxaprid | AA01FNW4
33225-51-3 | Maleic-2,3-d2 anhydride | AA01FO0L
251096-94-3 | 1-[(4-Chlorophenyl)sulfonyl]-2-pyrrolidinecarboxylic acid | AA01FO38
946682-60-6 | Methyl 2-(4-(2-amino-4-chlorophenoxy)phenyl)acetate | AA01FO60
1103191-48-5 | 1-(2-Cyanophenyl)piperidine-2-carboxylic acid | AA01FO8T
1171916-91-8 | (1-Isobutyryl-piperidin-4-yl)-acetic acid | AA01FOBH | MFCD12028495
1262412-28-1 | (2-Oxo-pyrrolidin-1-yl)-phenyl-acetic acidethyl ester | AA01FOEG | MFCD16875527
66557-84-4 | (3-METHYL-BUTYL)-HYDRAZINE | AA01FOHR | MFCD02656439
2098425-93-3 | 2-ethoxy-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | AA01FOKQ | MFCD28015460